Paragon Solutions, a business consulting and information technology services firm, announced the launch of solutions to optimize clinical operations incorporating the NextDocs product suite. The clinical solutions combine the capabilities of the two partners to deploy low-risk, accelerated solutions for life sciences built on Microsoft Office SharePoint Server.
“With the growing adoption of SharePoint within Life Sciences organizations, companies are looking for solution accelerators that leverage enterprise platforms to optimize the end-to-end drug development process,” said Ravi Shankar, vice president of Paragon’s Life Sciences practice. “NextDocs extends SharePoint with capabilities that complement our Clinical Optimization solution strategy,” he said.
The solutions leverage a strategic partnership formed by the companies in September 2009. One of the solutions the companies are introducing as part of the Clinical Optimization Solution portfolio is an integrated investigator portal. The portal is designed to deliver a collaborative environment that enables clinical sponsors and investigators to: negotiate contracts; define and communicating protocols; support site monitoring; manage grants; work with partners; and improve oversight and planning.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.